Back to Ovarian Cancer
NCT01689714
NCT01689714
Who may be able to join
Who might be able to join this trial:
- You must be 18 years of age or older.
- You must have a known or strongly suspected diagnosis of ovarian cancer, or returning endometrial cancer, with at least one detectable growth larger than 1.5 cm that has been seen on an ultrasound, MRI, or CT scan.
- You must have good kidney function.
- You must be willing and able to sign a consent form before joining the study.
Who may not be able to join:
- You are currently pregnant or breastfeeding.
- You are already taking part in another clinical trial involving an experimental drug.
- You finished the follow-up period of a previous clinical study less than 30 days before joining this trial.
- You are unable to tolerate the conditions involved in a type of medical scan that uses small amounts of radioactive material (confirm with trial site).
- You have recently been given another radioactive imaging substance that could interfere with the results of the scan being studied in this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Endocyte
Registry
clinicaltrials_gov
Start date
1 August 2003
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.